Your session is about to expire
← Back to Search
Procedure
Laser Treatment for Basal Cell Carcinoma
N/A
Recruiting
Led By Christopher Zachary, MBBS FRCP
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 18 and older
Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial showed that laser treatment of basal cell carcinoma was more effective when guided by optical coherence tomography.
Who is the study for?
This trial is for adults over 18 with a confirmed diagnosis of basal cell carcinoma (BCC) who are seeking treatment and can follow instructions or have someone to help them. It's not for pregnant individuals, those unable to commit to a full year of follow-up, patients with BCCs on legs or near the eyes, or cases where the cancer is too large, deep, high-risk or has spread.Check my eligibility
What is being tested?
The study tests how well a type of laser called the 1064 nm long-pulse Nd:YAG can treat basal cell carcinoma when guided by optical coherence tomography—a technique that uses light waves to take cross-section pictures of skin.See study design
What are the potential side effects?
While specific side effects aren't listed here, laser treatments may generally include redness, swelling at the treatment site, discomfort during the procedure, potential burns or blisters if not done correctly and changes in skin pigmentation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am scheduled for treatment of a biopsy-confirmed basal cell carcinoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Complete clearance of BCC lesion
Secondary outcome measures
Cosmetic outcome
Trial Design
2Treatment groups
Active Control
Group I: StandardActive Control1 Intervention
1064 Long-pulse Nd:YAG laser Fluence: 120 J/cm2 Number of passes: Single Spot size: 2 cm Pulse width: 8-10 msec
Group II: SlowActive Control1 Intervention
1064 Long-pulse Nd:YAG laser Fluence: 20-30 J/cm2 Number of passes: Multiple Spot size: 2 cm Pulse width: 8-10 msec
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
546 Previous Clinical Trials
1,923,161 Total Patients Enrolled
Christopher ZacharyLead Sponsor
Christopher Zachary, MBBS FRCPPrincipal InvestigatorUniversity of California, Irvine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have skin cancer on my legs that might not heal well.My skin cancer near the eye could be risky for laser treatment.I can understand and follow study instructions or have someone legally authorized to help me.I need to have a skin lesion removed that is either large, deep, high-risk, or has spread.I am 18 years old or older.I am scheduled for treatment of a biopsy-confirmed basal cell carcinoma.You are pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: Standard
- Group 2: Slow
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger